Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Purchase Now

Where data empowers pharma, payers and key stakeholders toward a shared purpose – Europe’s only home for RWE, data and access leaders.

Data dictates payer decisions and has the potential to provide a new guiding light for pharma companies. Real-World Evidence and Access Europe 2019 (March 12-14, Barcelona) is the summit that will help catalyse the healthcare landscape into a new world.

A place complete with key regulators, payers and HTAs, real-world insights, and leading European case studies - aiding in the creation of true value to allow patients the access to the drugs and treatments they need most.

Key themes from 2018

Data is differentiation:

Enhance your real-world study and analytical capabilities to provide sharper insights

Unite stakeholders:

Accelerate transition to a new data-led world by aligning pharma, payers and HTA around shared healthcare goals

Deliver intensity:

Create a focused pipeline where every payer relationship, every dataset and every internal goal gives you total dominance of your therapy area

Build what people want:

Ensure all departments, including clinical and R&D, are prioritising access goals and start with the patient in mind

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

A snapshot of the 2018's industry leading line-up

Market Access speakers

Florence Penicaud

UCB

Head of Market Access, Switzerland

Steve Wooding

Janssen

Head, Global Commercial and Market Access Strategy Organisation

Silvia Nicht

Takeda

Head of Market Access & Value Demonstration Europe & Canada

Nazanin Mehin
Nazanin Mehin

Sanofi

Global Head Value & Access, Cardiovascular

Real-World Evidence speakers

Bart Vannieuwenhuyse
Bart Vannieuwenhuyse

Janssen R&D

Senior Director Health Information Sciences

Chris Chinn

Sanofi

Head of Real World Investigations

Stefan Schröder
Stefan Schröder

Bayer

VP, Head of Data Generation & Business Excellence

Patrick Loerch

Celgene Corp

Sr. Director, Data Sciences

Interactive Payer & HTA roundtable discussions

Introduced as a new feature in 2018 - key Payer and HTAs from across Europe will be joining us to lead interactive discussions. Through conversations that transcend a single pipeline and tackle more fundamental bottle necks, we can foster new ways to work together and get the bet solutions for patients faster.

Italy

Belgium

Canada

Germany

UK

France

Poland

2 conferences: 1 pass.

The 2019 summit will bring you 2 conferences for the price of one ticket. One completely dedicated to market access, innovative pricing and reimbursement and the other dedicated to expanding the use of RWE internally across functions, building trust in RWE and influencing external decision makers. 

On the day there will be two tracks (see below) across two rooms running in parallel. You will have free movement between both, allowing you to pick and choose presentations at your choice. The networking times and areas will also be shared creating a diverse mix of attendees to discuss and collaborate with. 

 

The 2018 agenda at a glance

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

What our delegates are saying

Got a question? Get in touch below!

If you’re interested in getting involved in the 2019 summit, please contact us on the details below.

James Mackintosh

James Mackintosh

Global Project Director
eyeforpharma

Phone: +44 (0) 207 375 7163

Email: jmackintosh@eyeforpharma.com

Josh Bramwell

Josh Bramwell

Global Project Director
eyeforpharma

Phone: +44 (0) 207 375 7203

Email: jbramwell@eyeforpharma.com

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription